W. Martin Kast

22.2k total citations · 3 hit papers
280 papers, 18.2k citations indexed

About

W. Martin Kast is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, W. Martin Kast has authored 280 papers receiving a total of 18.2k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Immunology, 91 papers in Molecular Biology and 87 papers in Epidemiology. Recurrent topics in W. Martin Kast's work include Immunotherapy and Immune Responses (195 papers), Cervical Cancer and HPV Research (67 papers) and Immune Cell Function and Interaction (57 papers). W. Martin Kast is often cited by papers focused on Immunotherapy and Immune Responses (195 papers), Cervical Cancer and HPV Research (67 papers) and Immune Cell Function and Interaction (57 papers). W. Martin Kast collaborates with scholars based in United States, Netherlands and Italy. W. Martin Kast's co-authors include Diane M. Da Silva, Cornelis J.M. Melief, Cornelis J.M. Melief, Remco M.P. Brandt, Jan W. Drijfhout, Cornelis J.M. Melief, Markwin P. Velders, Rienk Offringa, Michel Vierboom and Sjoerd H. van der Burg and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

W. Martin Kast

277 papers receiving 17.7k citations

Hit Papers

Bone marrow-derived dendr... 1993 2026 2004 2015 1995 1994 1993 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
    1995 928 citations Walter J. Storkus, Cornelis J.M. Melief et al. profile →
  2. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
    1994 724 citations W. Martin Kast, C J Melief et al. profile →
  3. Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
    1993 709 citations Cornelis J.M. Melief, W. Martin Kast et al. European Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Martin Kast United States 72 13.0k 6.2k 4.8k 4.4k 1.9k 280 18.2k
Cornelis J.M. Melief Netherlands 75 17.7k 1.4× 7.0k 1.1× 8.8k 1.8× 3.8k 0.9× 1.7k 0.9× 233 22.4k
Rienk Offringa Netherlands 71 13.8k 1.1× 5.3k 0.8× 6.2k 1.3× 3.2k 0.7× 1.7k 0.9× 190 17.5k
Gerold Schuler Germany 84 25.1k 1.9× 7.8k 1.3× 7.7k 1.6× 2.4k 0.5× 2.0k 1.0× 355 33.0k
Jan W. Drijfhout Netherlands 77 11.4k 0.9× 6.8k 1.1× 3.7k 0.8× 4.2k 1.0× 2.6k 1.4× 319 21.2k
Sjoerd H. van der Burg Netherlands 80 17.1k 1.3× 7.2k 1.1× 10.6k 2.2× 4.4k 1.0× 1.4k 0.7× 338 23.6k
Stefan Stevanović Germany 68 11.2k 0.9× 8.7k 1.4× 4.1k 0.9× 2.4k 0.5× 1.1k 0.6× 344 18.4k
Esteban Celis United States 63 13.5k 1.0× 5.4k 0.9× 8.6k 1.8× 2.1k 0.5× 918 0.5× 205 18.7k
T.‐C. Wu United States 67 8.2k 0.6× 4.8k 0.8× 3.4k 0.7× 4.7k 1.1× 1.7k 0.9× 275 14.2k
Karolina Palucka United States 48 14.6k 1.1× 4.8k 0.8× 4.8k 1.0× 1.7k 0.4× 930 0.5× 126 19.0k
Adrian Hayday United Kingdom 81 17.0k 1.3× 4.7k 0.8× 5.5k 1.1× 1.4k 0.3× 1.6k 0.8× 236 23.3k

Countries citing papers authored by W. Martin Kast

Since Specialization
Citations

This map shows the geographic impact of W. Martin Kast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Martin Kast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Martin Kast more than expected).

Fields of papers citing papers by W. Martin Kast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Martin Kast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Martin Kast. The network helps show where W. Martin Kast may publish in the future.

Co-authorship network of co-authors of W. Martin Kast

This figure shows the co-authorship network connecting the top 25 collaborators of W. Martin Kast. A scholar is included among the top collaborators of W. Martin Kast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Martin Kast. W. Martin Kast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soto, Claradina, Lourdes Báezconde‐Garbanati, Jennifer B. Unger, et al.. (2023). Examining multilevel influences on parental HPV vaccine hesitancy among multiethnic communities in Los Angeles: a qualitative analysis. BMC Public Health. 23(1). 545–545. 26 indexed citations
2.
Monk, Bradley J., Takayuki Enomoto, W. Martin Kast, et al.. (2022). Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials. Cancer Treatment Reviews. 106. 102385–102385. 90 indexed citations
3.
Silva, Diane M. Da, Danielle Enserro, Jyoti Mayadev, et al.. (2020). Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929). Clinical Cancer Research. 26(21). 5621–5630. 54 indexed citations
4.
Woodham, Andrew W., Ross W. Cheloha, Jingjing Ling, et al.. (2018). Nanobody–Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses. Cancer Immunology Research. 6(7). 870–880. 24 indexed citations
5.
Singh, Anupam, et al.. (2018). A Cancer Education Curriculum for Underserved Elementary School Children. 1(8). 1 indexed citations
6.
Woodham, Andrew W., Joseph G. Skeate, Julia R. Taylor, et al.. (2016). Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment. AIDS Patient Care and STDs. 30(7). 291–306. 37 indexed citations
7.
Silva, Diane M. Da, Andrew W. Woodham, Paul H. Naylor, et al.. (2015). Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells. Journal of Interferon & Cytokine Research. 36(5). 291–301. 8 indexed citations
8.
Chiriva‐Internati, Maurizio, Yuefei Yu, Leonardo Mirandola, et al.. (2011). Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. The Prostate. 72(1). 12–23. 40 indexed citations
9.
Chiriva‐Internati, Maurizio, Leonardo Mirandola, Yuefei Yu, et al.. (2011). Cancer Testis Antigen, Ropporin, Is a Potential Target for Multiple Myeloma Immunotherapy. Journal of Immunotherapy. 34(6). 490–499. 18 indexed citations
10.
Smith, Kevin M., Victor Tam, Robb R. Pagarigan, et al.. (2009). Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors. Clinical Cancer Research. 15(19). 6167–6176. 28 indexed citations
11.
12.
Yu, Yuefei, Wei Zhou, Nicoletta Gagliano, et al.. (2008). rAAV/Her-2/neu Loading of Dendritic Cells for a Potent Cellular-Mediated MHC Class I Restricted Immune Response Against Ovarian Cancer. Viral Immunology. 21(4). 435–442. 16 indexed citations
13.
García-Hernández, María de la Luz, et al.. (2008). Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity. Cancer Research. 68(3). 861–869. 138 indexed citations
14.
García-Hernández, María de la Luz, Andrew Gray, Bolyn Hubby, & W. Martin Kast. (2007). In vivo Effects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate Cancer. Cancer Research. 67(3). 1344–1351. 92 indexed citations
15.
Lau, Roy, et al.. (2007). Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs. International Immunology. 19(10). 1223–1234. 186 indexed citations
16.
17.
Keilholz, Ulrich, Jeffrey S. Weber, James H. Finke, et al.. (2002). Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy. Journal of Immunotherapy. 25(2). 97–138. 235 indexed citations
18.
Twuyver, E. van, et al.. (1989). ALLOGRAFT TOLERANCE INDUCTION IN ADULT MICE ASSOCIATED WITH FUNCTIONAL DELETION OF SPECIFIC CTL PRECURSORS. Transplantation. 48(5). 844–847. 24 indexed citations
19.
Kast, W. Martin, et al.. (1988). Mechanism of skin allograft enhancement across an H‐2 class I mutant difference. Evidence for involvement of veto cells. European Journal of Immunology. 18(12). 2105–2108. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelis J.M. Melief Breakdown of academic impact, for papers by Rienk Offringa Breakdown of academic impact, for papers by Gerold Schuler Breakdown of academic impact, for papers by Jan W. Drijfhout Breakdown of academic impact, for papers by Sjoerd H. van der Burg Breakdown of academic impact, for papers by Stefan Stevanović Breakdown of academic impact, for papers by Esteban Celis Breakdown of academic impact, for papers by T.‐C. Wu Breakdown of academic impact, for papers by Karolina Palucka Breakdown of academic impact, for papers by Adrian Hayday
Rankless by CCL
2026